Parkside Financial Bank & Trust Innoviva, Inc. Transaction History

Parkside Financial Bank & Trust

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $1,286 - $1,444	-104 Reduced 48.83%	109 $1,000
Q1 2023 May 04, 2023	SELL	$10.73 - $13.6 $300 - $380	-28 Reduced 11.62%	213 $2,000
Q3 2022 Nov 01, 2022	BUY	$11.61 - $15.22 $92 - $121	8 Added 3.43%	241 $3,000
Q2 2021 Aug 06, 2021	BUY	$11.45 - $13.96 $229 - $279	20 Added 9.39%	233 $3,000
Q4 2020 Feb 09, 2021	BUY	$9.33 - $12.48 $233 - $312	25 Added 13.3%	213 $3,000
Q1 2020 May 05, 2020	BUY	$8.11 - $15.23 $746 - $1,401	92 Added 95.83%	188 $2,000
Q4 2019 Jan 30, 2020	BUY	$10.28 - $14.38 $986 - $1,380	96 New	96 $1,000
Q3 2019 Nov 05, 2019	SELL	$10.05 - $14.55 $1,336 - $1,935	-133 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$13.1 - $14.95 $1,218 - $1,390	93 Added 232.5%	133 $2,000
Q1 2019 May 01, 2019	SELL	$13.69 - $20.06 $780 - $1,143	-57 Reduced 58.76%	40 $1,000
Q1 2018 May 02, 2018	BUY	$13.8 - $16.99 $552 - $679	40 Added 70.18%	97 $2,000
Q3 2017 Oct 27, 2017	BUY	$12.06 - $14.12 $687 - $804	57	57 $1,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.